Pain in Competitive Athletes With Physical Disabilities: Techniques, Support and Perceived Difficulties
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT05639842|
Recruitment Status : Completed
First Posted : December 6, 2022
Last Update Posted : December 6, 2022
- Study Details
- Tabular View
- No Results Posted
- How to Read a Study Record
|Condition or disease||Intervention/treatment|
|Pain Athletes Physical Disability||Other: Pain in competitive athletes with physical disabilities. Techniques for its management, support received and perceived difficulties.|
|Study Type :||Observational|
|Actual Enrollment :||413 participants|
|Official Title:||Pain in Competitive Athletes With Physical Disabilities: Techniques for Its Management, Support Received and Perceived Difficulties|
|Actual Study Start Date :||December 9, 2021|
|Actual Primary Completion Date :||December 9, 2021|
|Actual Study Completion Date :||April 17, 2022|
- Other: Pain in competitive athletes with physical disabilities. Techniques for its management, support received and perceived difficulties.
A total of 413 athletes with physical disabilities participated in the study, 157 Spanish athletes and 260 Latin American athletes. The athletes were contacted through different sports federations, Paralympic Committees and sports teams of people with disabilities.For the distribution of the questionnaire, the researcher made an initial telephone contact with the Spanish Paralympic Committee and the Spanish Sports Federation for People with Physical Disabilities, to explain the objectives of the study and ask for their collaboration in the dissemination. Subsequently, the information was officially sent to them by email.
- Cross-sectional surveys [ Time Frame: 5 months ]An ad-hoc questionnaire was developed with questions that sought to respond to the specific objectives of this study, taking into consideration the information obtained in the previous qualitative study. The questionnaire consisted of 74 questions, 68 closed multiple-choice and 6 open-ended, organised into six sections: characteristics of the athlete, how pain affects their sporting career, tolerance and acceptance of pain, techniques and strategies for managing pain, social support for pain management and finally difficulties in pain management. A Likert scale from 1 (very infrequently) to 5 (very often) was used.Depending on the interpretation of the questions asked in each section, higher scores mean a better or worse result.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
|Ages Eligible for Study:||15 Years to 60 Years (Child, Adult)|
|Sexes Eligible for Study:||All|
|Accepts Healthy Volunteers:||Yes|
|Sampling Method:||Probability Sample|
- Competitive athletes.
- Physical disability.
- Age without criteria.
- Failure to meet the inclusion criteria.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT05639842
|Sandra Constantino Murillo|
|Madrid, Spain, 28410|
|Principal Investigator:||Sandra Constantino Murillo||Universidad Politécnica de Madrid.|
|Responsible Party:||Sandra Constantino Murillo, Principal Investigator, Universidad Politecnica de Madrid|
|Other Study ID Numbers:||
|First Posted:||December 6, 2022 Key Record Dates|
|Last Update Posted:||December 6, 2022|
|Last Verified:||December 2022|
|Individual Participant Data (IPD) Sharing Statement:|
|Plan to Share IPD:||No|
|Studies a U.S. FDA-regulated Drug Product:||No|
|Studies a U.S. FDA-regulated Device Product:||No|
|Product Manufactured in and Exported from the U.S.:||No|